HTA284 Reimbursement Challenges for ATMPs in EU5: Learnings From Product Withdrawals and Implications for Future Development of Innovative Therapies
Abstract
Authors
Viktor Danev Gerdi Strydom Anna L. McCormick Stephen Hall Ines Oliveira